Abigail Doucette
Papers
2
Total Citations
7
H-Index
2
About
Abigail Doucette is a dedicated clinical researcher whose work focuses on optimizing treatment strategies for human papillomavirus (HPV)-associated tonsil cancer, a growing subset of head and neck malignancies. Her primary research areas include identifying pathologic risk factors for contralateral neck disease and refining patient selection for unilateral neck radiation therapy to reduce treatment-related morbidity. In her most-cited study (2019, 5 citations), Doucette investigated the risk of post-operative, pre-radiotherapy contralateral neck recurrence in patients treated with surgery and adjuvant radiotherapy, addressing a critical gap in understanding early contralateral disease. Her earlier work (2017, 2 citations) further delineated pathologic risk factors that guide clinicians in safely omitting contralateral neck irradiation, thereby minimizing toxicity without compromising oncologic outcomes. Though her citation counts are modest, Doucette’s contributions are highly relevant to the evolving paradigm of de-escalation therapy in HPV-positive oropharyngeal cancer. Her research provides actionable insights for tailoring radiotherapy fields, directly impacting patient quality of life. For students and researchers, Doucette exemplifies how focused, clinically driven studies can influence treatment guidelines and improve outcomes in a specific, high-impact disease context.
Research Focus
Key Achievements
Top Papers
- 1
- 2